Literature DB >> 192180

Immunoprecipitation of herpes simplex virus type 1 antigens with different antisera and human cerebrospinal fluids.

G Pauli, H Ludwig.   

Abstract

Rabbit convalescent and hyperimmune sera, human patient and blood donor sera, as well as cerebrospinal fluids of humans with herpes simplex virus encephalitis all recognize similar major antigenic components in herpes simplex virus infected rabbit or human cells as shown by electrophoretic analysis of immunoprecipitates. Besides the main glycoproteins with an apparent molecular weight of 100,000 (peak I) the antisera precipitate glycoproteins in a region of an apparent mol. wt. of 60,000--80,000 (peak II), which were resolved into distinct glycoprotein species only by antibody-containing cerebrospinal fluids. The peak II glycoproteins appear on the surface of the infected cell early, and absorb neutralizing antibodies, whereas the peak I glycoproteins are less accessible. Both antigens can be demonstrated in the cell as early as about 2 hours post infection. All major antigenic components studied were found to be glycosylated except one protein with an apparent mol. wt. of 110,000. The herpesvirus specificity of these antigens is demonstrated by a variety of control experiments. The antigens detected are virion components.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192180     DOI: 10.1007/bf01314855

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  35 in total

1.  Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.

Authors:  R N Lausch; C Jones; D Christie; K A Hay; F Rapp
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies.

Authors:  K E Schneweis; A J Nahmias
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

3.  The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion.

Authors:  H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

4.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

5.  Radioimmune assay of carcinoembryonic antigen.

Authors:  M L Egan; J T Lautenschleger; J E Coligan; C W Todd
Journal:  Immunochemistry       Date:  1972-03

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos.

Authors:  M S Halpern; D P Bolognesi; R R Friis; W S Mason
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

Review 8.  Immunology of herpes simplex virus infection: relevance to herpes simplex virus vaccines and cervical cancer.

Authors:  A J Nahmias; S L Shore; S Kohl; S E Starr; R B Ashman
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

9.  Separation of Herpes simplex virus-induced antigens by Concanavalin A affinity chromatography.

Authors:  M Ponce de Leon; H Hessle; G H Cohen
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

10.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

View more
  15 in total

1.  Bovine and ovine leukemia viruses. I. Characterization of viral antigens.

Authors:  W Rohde; G Pauli; J Paulsen; E Harms; H Bauer
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

2.  Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.

Authors:  B Norrild; S L Shore; T L Cromeans; A J Nahmias
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

3.  Herpesvirus simiae (B virus): replication of the virus and identification of viral polypeptides in infected cells.

Authors:  J K Hilliard; R Eberle; S L Lipper; R M Munoz; S A Weiss
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Compartment-specific immunolocalization of conserved epitopes of the glycoprotein gB of herpes simplex virus type 1 and bovine herpes virus type 2 in infected cells.

Authors:  S M Pietschmann; H R Gelderblom; G Pauli
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Evidence for a Gp85-related glycoprotein in cells transformed by the Bryan high titer strain of Rous sarcoma virus.

Authors:  G Pauli; B Fleischer
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

7.  Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay.

Authors:  P Markoulatos; A Georgopoulou; N Siafakas; E Plakokefalos; G Tzanakaki; J Kourea-Kremastinou
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

8.  Detection of viral antigens in cerebrospinal fluid of rabbits with experimental herpes simplex virus type 1 encephalitis.

Authors:  C A Bos; J B Wilterdink; A J Scheffer
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  The cerebrospinal fluid of rabbits infected with Borna disease virus.

Authors:  H Ludwig; V Koester; G Pauli; R Rott
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.